Proliferative index determination in prostatic carcinoma tissue: Is there any additional prognostic value greater than that of gleason score, ploidy and pathological stage?

Journal of Urology

Volumn 157, Issue 1, 1997, Pages 214-218

  Coetzee, Lance J ^a   Layfield, Lester J ^a   Hars, Veronika ^a   Paulson, David F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

neoplasm invasiveness; neoplasm staging; ploidies; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER STAGING; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA; PROSTATECTOMY;

EID: 0031060568     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65329-1     Document Type: Article

References (24)

1. Pontes, J. E., Wajsman, Z., Huben, R. P., Wolf, R. M. and Englander, L. S.: Prognostic factors in localized prostatic carcinoma. J. Urol., 134: 1137, 1985.
2. Jewett, H. J., Eggleston, J. C. and Yawn, D. H.: Radical prostatectomy in the management of carcinoma of the prostate: probable causes of some therapeutic failures. J. Urol., 107: 1034, 1972.
3. Walsh, P. C. and Jewett, H. J.: Radical surgery for prostate cancer. Cancer, 45: 1906, 1980.
4. Paulson, D. F., Stone, A. R., Walther, P. J., Tucker, J. A. and Cox, E. B.: Radical prostatectomy: anatomical predictors of success or failure. J. Urol., 136: 1041, 1986.
5. Gleason, D. F.: Classification of prostate carcinomas. Cancer Chemother. Rep., 50: 125, 1966.
6. Utz, D. C. and Farrow, G. M.: Pathological differentiation and prognosis of prostatic carcinoma. J.A.M.A., 209: 1701, 1969.
7. Barzell, W., Bean, M. A., Hilaris, B. S. and Whitmore, W. F., Jr.: Prostatic adenocarcinoma: relationship of grade and local extent to the pattern of metastases. J. Urol., 118: 278, 1977.
8. Zincke, H., Farrow, G. M., Myers, R. P., Benson, R. C., Jr., Furlow, W. L. and Utz, D. C.: Relationship between grade and stage of adenocarcinoma of the prostate and regional pelvic lymph node metastases. J. Urol., 128: 498, 1982.
9. Wilson, J. W. L., Morales, A. and Bruce, A. W.: The prognostic significance of histologic grading and pathologic staging in carcinoma of the prostate. J. Urol., 130: 481, 1983.
10. Grigioni, W. F., D'Errico, A., Bacci, F., Gaudio, M., Mazziotti, A., Gozzetti, G. and Mancini, A. M.: Primary liver neoplasms: evaluation of proliferative index using MoAb Ki 67. J. Path., 158: 23, 1989.
11. Meyer, J. S.: The cell-proliferative index. Cancer Invest., 8: 247, 1990.
12. Layfield, L. J., Dodge, R. K., Conlon, D. H. and Lininger, R.: Determination of proliferative index by MIB-1 in early stage breast cancer using quantitative image analysis. Breast J., 1: 362, 1995.
13. Gleason, D. F., Mellinger, G. T. and the Veterans Administration Cooperative Research Group: Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J. Urol., 111: 58, 1974.
14. Humphrey, P. A., Walther, P. J., Currin, S. M. and Vollmer, R. T.: Histologic grade, DNA ploidy, and intraglandular extent as indicators of tumor progression of clinical stage B prostate carcinoma. A direct comparison. Amer. J. Surg. Path., 15:1165, 1991.
15. Ritchie, A. W. S., Dorey, F., Layfield, L. J., Hannah, J., Lovrekovich, H. and deKernion, J.: Relationship of DNA content to conventional prognostic factors in clinically localised carcinoma of the prostate. Brit. J. Urol., 62: 254, 1988.
16. Haugen, O. A. and Mjølnerø, O.: DNA-ploidy as prognostic factor in prostatic carcinoma. Int. J. Cancer, 45: 224, 1990.
17. Spires, S. E., Banks, E. R., Davey, D. D., Jennings, C. D., Wood, D. P., Jr. and Cibull, M. L.: Proliferating cell nuclear antigen in prostatic adenocarcinoma: correlation with established prognostic indicators. Urology, 43: 660, 1994.
18. Paulson, D. F. and Walther, P. J.: Is grade or stage of primary importance in determining the outcome after radical prostatectomy for disease clinically confined to the prostate? Brit. J. Urol., 63: 301, 1989.
19. de las Morenas, A., Siroky, M. B., Merriam, M. J. and Stilmant, M. M.: Prostatic adenocarcinoma: reproducibility and correlation with clinical stages of four grading systems. Hum. Path., 19: 595, 1988.
20. Nemoto, R., Kawamura, H., Miyakawa, I., Uchida, K., Hattori, K., Koiso, K. and Harada, M.: Immunohistochemical detection of proliferating cell nuclear antigen (PCNA)/cyclin in human prostate adenocarcinoma. J. Urol., 149: 165, 1993.
21. Visakorpi, T.: Proliferative activity determined by DNA flow cytometry and proliferating cell nuclear antigen (PCNA) immunohistochemistry as a prognostic factor in prostatic carcinoma. J. Path., 168: 7, 1992.
22. Greene, D. R., Rogers, E., Wessels, E. C., Wheeler, T. M., Taylor, S. R., Santucci, R. A., Thompson, T. C. and Scardino, P. T.: Some small prostate cancers are nondiploid by nuclear image analysis: correlation of deoxyribonucleic acid ploidy status and pathological features. J. Urol., 151: 1301, 1994.
23. Hussain, M. H., Powell, I., Zaki, N., Maciorowski, Z., Sakr, W., KuKuruga, M., Visscher, D., Haas, D. P., Pontes, J. E. and Ensley, J. F.: Flow cytometric DNA analysis of fresh prostatic resections. Correlation with conventional prognostic parameters in patients with prostate cancer. Cancer, 72: 3012, 1993.
24. Epstein, J. I., Pizov, G., Steinberg, G. D., Carter, H. B., Pitcock, R., Armes, O. A., Partin, A. and Walsh, P. C.: Correlation of prostate cancer nuclear deoxyribonucleic acid, size, shape, and Gleason grade with pathological stage at radical prostatectomy. J. Urol., 148: 87, 1992.